194 results about "Blood Glucose Measurement" patented technology

The present invention relates to a body attachment unit for continuous blood glucose monitoring, in which a body attachment unit is manufactured so as to be assembled in an applicator, thereby minimizing additional work and allowing attachment of the body attachment unit to a body simply by operation of the applicator. In particular, a wireless communication chip is provided in the body attachment unit to enable communication with an external terminal, thereby enabling simple and convenient use without additional work of connecting a separate transmitter, and allowing easier maintenance. In addition, activation occurs by a user's operation after the body attachment unit is attached to the body, such that an activation start time can be adjusted to a time appropriate to the user's needs, and activation can occur in a stabilized state, and thereby allowing more accurate blood glucose monitoring.

Blood glucose level measurement includes a light source configured to irradiate light to a subject; a monochrome part configured to separate wavelength components of the light that is reflected and scattered from the subject; a light receiver configured to receive the light transmitted via the monochrome part and to generate electrical signals based on the received light; and a processor configured to extract information on the blood glucose level of the subject based on a frequency shift of the light due to the Raman effect.

A personalized non-invasive blood glucose measurement method according to the present disclosure includes: (a) collecting blood glucose value data of a patient by a processor unit; (b) determining an acceptable final error E′ with the blood glucose value data collected by the processor unit; (c) non-invasively predicting a blood glucose value in accordance with a setting mode by a patient when the final error E′ is determined, to measure a blood glucose value, by the processor unit; (d) periodically determining whether the final error E′ is calibrated by the processor unit; and (e) when it is not necessary to recalibrate in step (d), non-invasively predicting the blood glucose value in the range of the final error E′ determined in step (b) to measure the blood glucose value, to non-invasively provide an accurate personalized blood glucose value to a patient who needs to invasively measure a blood glucose every day.

A wearable smart insole for a user having foot having a planter arch and a medial plantar artery (MPA) along the plantar arch is provided. The insole has at least one optical sensor disposed in the insole along the MPA, a power handling circuit, an energy storage module operatively coupled with the power handing circuit to provide power to the optical sensor. The optical sensor is disposed along the MPA in the insole and provides a signal for obtaining heart rate data, blood oxygen saturation data and blood glucose measurements. Two optical sensors may be provided along the MPA to provide signals for calculating blood pressure. A third optical sensor may be provided along the lateral plantar artery to provide signals to detect diabetes or arterial disease.

Blood glucose level measurement includes a light source configured to irradiate light to a subject; a monochrome part configured to separate wavelength components of the light that is reflected and scattered from the subject; a light receiver configured to receive the light transmitted via the monochrome part and to generate electrical signals based on the received light; and a processor configured to extract information on the blood glucose level of the subject based on a frequency shift of the light due to the Raman effect.

Blood glucose level measurement includes a light source configured to irradiate light to a subject; a monochrome part configured to separate wavelength components of the light that is reflected and scattered from the subject; a light receiver configured to receive the light transmitted via the monochrome part and to generate electrical signals based on the received light; and a processor configured to extract information on the blood glucose level of the subject based on a frequency shift of the light due to the Raman effect.

This invention discloses a time-division multiplexed dual-mode monitoring sensor for blood glucose and implanted wound infection, and its monitoring method. The sensor includes an electrically connected sensing unit and a detection unit. The sensing unit includes a three-electrode system of sensing electrodes, and the detection unit includes a chronoamperometry circuit for blood glucose measurement, an open-circuit voltage method circuit for wound pH measurement, a switching circuit, and a control module. The control module regulates the switching circuit, enabling the sensor to alternately perform blood glucose and implanted wound pH measurements in a time-division multiplexed manner. Based on the pH measurement data, the blood glucose measurement results can be dynamically calibrated, and an alarm is triggered when the wound infection level measured by the pH measurement data exceeds a preset threshold. This invention optimizes the combination relationship of the three-electrode system and the timing control of the detection modes, achieving simultaneous detection of two indicators without adding additional electrodes. This not only improves detection accuracy and wearing comfort but also simplifies the device structure and reduces costs, showing great application potential.

The utility model discloses a temperature self-correcting implantable blood glucose sensor. The sensor mainly comprises a bin body, a power supply, a main board, a blood glucose processing module, a temperature correcting module, a Bluetooth receiving and transmitting module and a sensor probe module. The sensor probe module comprises a temperature detection electrode and a blood glucose detection electrode. Wherein the temperature detection electrode is an integrated electrode based on a thermistor, is attached to the surface of the blood glucose detection electrode and is used for detecting and sensing the real-time temperature of an implantation part, and the temperature change is fed back to the blood glucose detection module for correction, so that the measurement accuracy is improved. The device has the advantages of simple structure, high measurement accuracy, no environmental influence and the like, and is suitable for improving the long-term working stability of implantable blood glucose measurement equipment and the like.

Embodiments may relate to systems and methods for real-time automatic detection of sensor pressure in continuous blood glucose monitoring. A system may include at least one sensor and at least one processor in communication with the at least one sensor. The at least one processor is programmed or configured to cause the processor to: retrieve first measurement data, the first measurement data comprising at least one time series of blood glucose (BG) measurements measured by the at least one sensor while not being compressed; receiving, from the at least one sensor, second measurement data comprising at least one BG measurement; determining a gap value between BG measurements based on the first measurement data and the second measurement data; and generating a signal output indicating that the at least one sensor is compressed based on the value of the gap between the BG measurements exceeding a predefined threshold.

The present disclosure relates to a body attachment unit for continuous blood glucose measurement, in which the body attachment unit is manufactured so as to be assembled in an applicator, thereby minimizing additional work and allowing attachment of the body attachment unit to a body simply by operation of the applicator. In particular, a wireless communication chip is provided in the body attachment unit to enable communication with an external terminal, thereby enabling simple and convenient use without performing additional work of connecting a separate transmitter, and allowing easier maintenance. In addition, activation occurs by a user's operation after the body attachment unit is attached to the body, such that an activation start point in time can be adjusted to an appropriate point in time according to the user's needs, and activation occurs in a stabilized state, thereby providing the body attachment unit allowing more accurate blood glucose measurement.

The invention discloses an enzyme electrode method efficient blood glucose measuring device for real-time monitoring of diabetes, and relates to the technical field of blood glucose detection. The enzyme electrode method efficient blood glucose measuring device for real-time monitoring of diabetes mellitus comprises a detection box main body, a detection cavity is formed in the detection box main body, a detection opening used for stretching of the arm of a patient is formed in one side of the detection box main body, and a placement module is arranged in the detection cavity and used for bearing the arm, stretching into the detection opening, of the patient; a pressing limiting structure is arranged at the upper end of the placement module, and the bottom of the detection box main body is hollow and is provided with a supporting unit capable of being quickly opened and closed. According to the blood glucose measuring device, the blood sampling mode of the vein blood vessel of the arm of a patient is adopted to replace fingertip blood sampling, blood sampling obtained through fingertip blood sampling is capillary whole blood and contains tissue fluid, the measuring result is lower than the actual value, and the effect of venous blood sampled through the vein blood vessel is more accurate; the system is more suitable for real-time monitoring of patients in daily life.

Exemplary embodiments relate to drug delivery devices, such as automated insulin delivery (AMD) devices. The described methods and apparatuses allow an AMD device to be initialized and / or operated with little or no user input. Exemplary logic initializes the AMD device to operate with known-safe drug delivery parameters that leverage the AMD device's ability to monitor blood glucose levels at short intervals and continuously deliver small amounts of insulin. The AMD then rapidly adapts the parameters and system constraints based on current and historical glucose measurements. Further embodiments provide for the detection of events that result in disturbances to glucose control, and to adaptation of alert frequency based on user behavior.

The present application relates to the technical field of blood glucose monitoring, in particular to a continuous blood glucose monitoring device and a continuous blood glucose monitoring system. The continuous blood glucose monitoring device comprises a flexible substrate and a transmitter component, the flexible substrate can be fixed on the surface of the skin, the first printed line is drawn on the flexible substrate, the transmitter component is welded on the flexible substrate and is electrically connected with the first printed line, the flexible substrate comprises an elongated lead-out end, the second printed line for monitoring blood glucose level is arranged on the lead-out end, and the second printed line is communicated with the first printed line. The continuous blood glucose monitoring device and the continuous blood glucose monitoring system integrate the sensor component and the transmitter component, and there is no PAD area, so that the overall thickness of the continuous blood glucose measuring device is relatively thin, and the sensor component and the transmitter component have reliable signal connection.

The present invention generally relates to implantable continuous blood glucose measurement technology. In particular, the present invention relates to an implantable continuous blood glucose measurement device for continuously measuring blood glucose in the body of a user, in which an oscillator for generating a variable frequency output signal corresponding to a voltage or current applied to both ends thereof is connected to a glucose fuel cell for generating electrical energy by glucose in the body, comprises an LED element, which is turned on or off by the output signal of the oscillator, or an antenna for wirelessly transmitting the output signal of the oscillator. The present invention has the advantage that blood glucose can be continuously measured in a state in which a blood glucose sensor is implanted in the body, without having to replace same.

The invention relates to the technical field of application of recuperating medicine boxes, in particular to a portable recuperating medicine box which comprises a tool storage layer and a medicine storage layer, the tool storage layer of the portable recuperating medicine box plays a role of a'logistics center 'in the recuperating medicine box, and tool grids and cup grooves are formed in the tool storage layer at the same time; the two requirements of'recuperating equipment 'and'medicine taking and water drinking' are integrated on the same horizontal level. The tool grid is a square deep cavity and exactly contains the tool carrying box, and the tool carrying box can be integrally drawn out and independently carried, so that required instruments only need to be placed in the box at one time before going out, repeated rummaging is not needed during subsequent multiple times of going out, and omission is avoided. The cup groove is located beside the tool grid, a user can directly take the cup and take medicine on the same side after completing operations such as blood pressure measurement and blood sugar measurement, the moving line is shortened, and the risk of instrument pollution caused by walking back and forth is reduced. Positioning sleeves are reserved at the four corners of the top face of the tool storage layer, and an inserting reference is provided for the upper medicine storage layer.

In an electronic device and an operation method of the electronic device, according to one embodiment, the electronic device may comprise: a light source unit for generating lights of a plurality of wavelength bands; an optical body for irradiating the lights of the plurality of wavelength bands onto the skin of a user; a light-receiving unit for detecting light obtained by reflecting the lights of the plurality of wavelength bands from the skin of the user; a memory for storing at least one computer program including instructions; and at least one processor. When individually or collectively executed by the at least one processor, the instructions can instruct the electronic device to: acquire the intensity of irradiation light of a specific wavelength band irradiated from the light source unit at the user and the intensity of reflected light obtained by reflecting the irradiation light of the specific wavelength band from the user; calculate the response gain of the irradiation light of the specific wavelength band on the basis of the ratio of the intensity of the irradiation light to the intensity of the reflected light; and identify a blood glucose level corresponding to the calculated response gain by using a blood glucose level database including blood glucose level information corresponding to the response gain of each of irradiation lights of the plurality of wavelength bands.

An embodiment of the present invention provides a method for providing a signal loss notification in a blood glucose measurement system, comprising: a step in which a terminal delays a signal loss notification for a first period when a communication failure occurs between the terminal and a sensor transmitter; a step in which the terminal further determines whether a signal loss continues during a second period when the communication failure continues during the first period; a step in which the terminal generates the signal loss notification when the signal loss continues during the second period; and a step in which the terminal outputs the signal loss notification to a user.

To improve a health management method.SOLUTION: A health management method (100) includes: a first step in which a non-invasive blood glucose measurement device (1) generates blood glucose curve data (50) and transmits the data to a subject terminal device (2); a second step in which the subject terminal device (2) transmits subject information (6) including the blood glucose curve data (50) to an administrator computer (3); and a third step in which the administrator computer (3) generates advice information (5) and transmits the advice information (5) to the subject terminal device (2), the advice information (5) including a result of determination as to whether a blood glucose spike is present.SELECTED DRAWING: Figure 2

A method of administering insulin includes receiving blood glucose measurements of a patient at a data processing device from a glucometer. Each blood glucose measurement is separated by a time interval and includes a blood glucose time associated with a time of measuring the blood glucose measurement. The method also includes receiving patient information at the data processing device and selecting a subcutaneous insulin treatment for tube-fed patients from a collection of subcutaneous insulin treatments. The selection is based on the blood glucose measurements and the patient information. The subcutaneous insulin treatment program for tube-fed patients determines recommended insulin doses based on the blood glucose times. The method also includes executing, using the data processing device, the selected subcutaneous insulin treatment.

1.The name of the design product: blood glucose meter (for children). 2.The use of the design product: the design product is used for blood glucose measurement of children with diabetes. 3.The design points of the design product: the combination of shape and color. 4.The picture or photo that best shows the design points: perspective view. 5.The design claimed contains color.

Method and apparatus for optimizing analyte sensor calibration including receiving a current blood glucose measurement, retrieving a time information for an upcoming scheduled calibration event for calibrating an analyte sensor, determining temporal proximity between the current blood glucose measurement and the retrieved time information for the upcoming calibration event, initiating a calibration routine to calibrate the analyte sensor when the determined temporal proximity is within a predetermined time period, and overriding the upcoming scheduled calibration event using the current blood glucose measurement are provided.

Provided relates to a continuous blood glucose measurement device which is produced with an assembled body attachment unit inside an applicator so as to minimize a user's additional work of attaching the body attachment unit to the body, thereby enabling the body attachment unit to be attached to the body by simply activating the applicator, and which is provided with a wireless communication chip in a body attachment unit so as to enable communication with an external terminal, thereby enabling simple and convenient use, without additional work of connecting a separate transmitter, and easier maintenance; and is activated by the user after the body attachment unit is attached to the body so as to enable the operation start time to be adjusted to an appropriate time according to user's needs, and to enable the operation to start in a stabilized state so that blood glucose can be measured more accurately.

The present invention relates to a non-invasive blood glucose measuring apparatus, for measuring the glucose level in an object of measurement, comprising: (a) an irradiation source, for irradiating a narrow-band wavelength light into said object of measurement containing a blood vessel; (b) an optical detector, for collecting and processing some of the light, irradiated by said irradiating source, which is back-scattered from the object of measurement, (c) sampling means, for sampling said orthogonally polarized beams, provided by said detector-amplifiers, for converting the data of said orthogonally polarized beams into digital codes; and (d) a computing unit, wherein said computing unit comprises an adaptive filter for enhancing the cardiac pulse pulsatile waveform, and wherein said computing unit computes the glucose level, in said object of measurement, by averaging of said sampled codes.

Method and apparatus for optimizing analyte sensor calibration including receiving a current blood glucose measurement, retrieving a time information for an upcoming scheduled calibration event for calibrating an analyte sensor, determining temporal proximity between the current blood glucose measurement and the retrieved time information for the upcoming calibration event, initiating a calibration routine to calibrate the analyte sensor when the determined temporal proximity is within a predetermined time period, and overriding the upcoming scheduled calibration event using the current blood glucose measurement are provided.

Blood glucose level measurement includes a light source configured to irradiate light to a subject; a monochrome part configured to separate wavelength components of the light that is reflected and scattered from the subject; a light receiver configured to receive the light transmitted via the monochrome part and to generate electrical signals based on the received light; and a processor configured to extract information on the blood glucose level of the subject based on a frequency shift of the light due to the Raman effect.

Provided is a liquid medication control injection device including a blood glucose measuring unit configured to measure blood glucose of target of injection at least a plurality of times, sequentially, a first liquid medication injection unit configured to inject a first liquid medication containing a component for controlling a decrease in blood glucose of the target of injection to the target of injection, and a second liquid medication injection unit configured to inject a second liquid medication containing a component for controlling an increase in blood glucose of the target of injection, wherein the component of the second liquid medication is different from that of the first liquid medication.

An active Fano resonance blood glucose sensor, relating to the field of non-invasive blood glucose monitoring. The blood glucose sensor comprises a resonator, an excitation layer, a low-noise amplifier (8) and a phase shifter (9), wherein the resonator, the low-noise amplifier (8) and the phase shifter (9) form a connection loop; the resonator is provided on the excitation layer; and the excitation layer is connected to an external excitation source. By using the phase shifter (9), the phase of an active circuit can be changed to selectively enhance resonance, improve the resonance Q factor, and realize detection of minor changes in blood glucose concentration, and thus the active Fano resonance blood glucose sensor can be applied to human blood glucose sensing and the problems in the prior art of poor stability and robustness. Moreover, by using the resonator and the excitation layer, self-reference error elimination can be achieved, significantly improving the performance of the microwave blood glucose sensor and improving the reliability of blood glucose measurement.

Disclosed is a blood glucose measurement device capable of improving blood glucose measurement accuracy by focusing rays of light for blood glucose measurement in the measurement area of an object. According to an embodiment of the present invention, the blood glucose measurement device comprises: a light source unit disposed to output a plurality of first light rays for measuring blood glucose in the measurement area of an object; an optical unit including one or more optical bodies disposed to emit a plurality of first light rays toward the measurement area of the object; and a light-receiving unit disposed to receive a plurality of second light rays output through an interaction between the plurality of first light rays and the object. The one or more optical bodies include: a plurality of lenses arranged to condense a plurality of first light rays on the first surface of one or more optical bodies facing the light source unit; a reflective surface arranged to reflect a plurality of first light rays condensed by the plurality of lenses on the second surface of one or more optical bodies; and a refractive surface arranged to refract a plurality of first light rays reflected at the reflective surface toward the measurement area of the object on the third surface of one or more optical bodies.

Blood glucose level measurement includes a light source configured to irradiate light to a subject; a monochrome part configured to separate wavelength components of the light that is reflected and scattered from the subject; a light receiver configured to receive the light transmitted via the monochrome part and to generate electrical signals based on the received light; and a processor configured to extract information on the blood glucose level of the subject based on a frequency shift of the light due to the Raman effect.